JP2025500344A5 - - Google Patents
Info
- Publication number
- JP2025500344A5 JP2025500344A5 JP2024537375A JP2024537375A JP2025500344A5 JP 2025500344 A5 JP2025500344 A5 JP 2025500344A5 JP 2024537375 A JP2024537375 A JP 2024537375A JP 2024537375 A JP2024537375 A JP 2024537375A JP 2025500344 A5 JP2025500344 A5 JP 2025500344A5
- Authority
- JP
- Japan
- Prior art keywords
- sleep apnea
- respiratory disorders
- norepinephrine reuptake
- combination
- snoring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21216872 | 2021-12-22 | ||
| EP21216872.8 | 2021-12-22 | ||
| PCT/EP2022/086965 WO2023118123A1 (en) | 2021-12-22 | 2022-12-20 | Combination of an α2-adrenoceptor subtype c (alpha-2c) antagonist with a norepinephrine reuptake inhibitor for the treatment of sleep apnea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500344A JP2025500344A (ja) | 2025-01-09 |
| JP2025500344A5 true JP2025500344A5 (https=) | 2025-12-05 |
Family
ID=80225456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537375A Pending JP2025500344A (ja) | 2021-12-22 | 2022-12-20 | 睡眠時無呼吸の治療のためのα２－アドレナリン受容体サブタイプＣ（アルファ－２Ｃ）アンタゴニストとノルエピネフリン再取込み阻害薬との組合せ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250049779A1 (https=) |
| EP (1) | EP4452242A1 (https=) |
| JP (1) | JP2025500344A (https=) |
| KR (1) | KR20240124995A (https=) |
| CN (1) | CN118475347A (https=) |
| AU (1) | AU2022418121A1 (https=) |
| CA (1) | CA3256789A1 (https=) |
| IL (1) | IL313646A (https=) |
| MX (1) | MX2024007768A (https=) |
| TW (1) | TW202342033A (https=) |
| WO (1) | WO2023118123A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966781A (en) | 1970-12-17 | 1976-06-29 | Merck Sharp & Dohme (I.A.) Corporation | Deuteration of functional group-containing hydrocarbons |
| HRP20041026A2 (en) | 2002-04-03 | 2005-06-30 | Orion Corporation | Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| US8791162B2 (en) | 2011-02-14 | 2014-07-29 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
| WO2017031319A1 (en) | 2015-08-18 | 2017-02-23 | Massachusetts Institute Of Technology | Noradrenergic drug treatment of obstructive sleep apnea |
| GEAP202416602A (en) | 2017-04-28 | 2024-10-10 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| KR102874891B1 (ko) | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
| MX2021004883A (es) * | 2018-10-31 | 2021-08-05 | Apnimed Inc Delaware | Metodos y composiciones para tratar apnea del sue?o. |
| PE20221025A1 (es) | 2019-11-06 | 2022-06-16 | Bayer Ag | Inhibidores de los receptores a2c adrenergicos |
-
2022
- 2022-12-20 KR KR1020247023957A patent/KR20240124995A/ko active Pending
- 2022-12-20 CN CN202280085098.8A patent/CN118475347A/zh active Pending
- 2022-12-20 EP EP22840709.4A patent/EP4452242A1/en active Pending
- 2022-12-20 US US18/722,189 patent/US20250049779A1/en active Pending
- 2022-12-20 CA CA3256789A patent/CA3256789A1/en active Pending
- 2022-12-20 MX MX2024007768A patent/MX2024007768A/es unknown
- 2022-12-20 AU AU2022418121A patent/AU2022418121A1/en active Pending
- 2022-12-20 TW TW111148911A patent/TW202342033A/zh unknown
- 2022-12-20 WO PCT/EP2022/086965 patent/WO2023118123A1/en not_active Ceased
- 2022-12-20 IL IL313646A patent/IL313646A/en unknown
- 2022-12-20 JP JP2024537375A patent/JP2025500344A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7422666B2 (ja) | 睡眠時無呼吸を治療するための方法および組成物 | |
| EP2148670B1 (en) | Titration of tapentadol | |
| JP2020517719A5 (https=) | ||
| US20200197388A1 (en) | Treatments for depression and other diseases with a low dose agent | |
| JP5796959B2 (ja) | 関節炎における痛みの治療のためのタペンタドール | |
| JP2010512413A5 (https=) | ||
| JP2008524332A (ja) | 睡眠傷害のための医薬組成物 | |
| JP2009536176A5 (https=) | ||
| US20100160294A1 (en) | Tolerability of mirtazapine and a second active by using them in combination | |
| JP2025508406A5 (https=) | ||
| US20090275562A1 (en) | Tolerability of mirtazapine and a second active by using them in combination | |
| CN113453683A (zh) | 运动障碍的治疗 | |
| JP2022506113A5 (https=) | ||
| TW200800148A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient | |
| PT1628652E (pt) | Combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão | |
| JP2025500344A5 (https=) | ||
| JP2007523052A (ja) | 鬱病の処置のための蘇生薬モダフィニルおよび抗鬱薬の組み合わせ | |
| US20090048233A1 (en) | Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination | |
| US20240277719A1 (en) | Norepinephrine reuptake inhibitors for treating sleep apnea | |
| JP2025500346A5 (https=) | ||
| JP2024511091A5 (https=) | ||
| JP2023520455A (ja) | 睡眠時無呼吸を治療するための方法および組成物 | |
| JP2025527796A (ja) | 睡眠時無呼吸を治療するための方法及び組成物 | |
| WO2024220343A1 (en) | Combination of a norepinephrine reuptake inhibitor and a melatonin receptor agonist for use in treating sleep apnea | |
| JP2005500368A5 (https=) |